| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/18/2008 | WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor |
| 12/18/2008 | WO2008151745A1 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 12/18/2008 | WO2008151388A1 Methods of initiating insulin production |
| 12/18/2008 | WO2008087491A3 Method for treating or preventing symptoms of hormonal variations |
| 12/18/2008 | US20080312135 Mixtures of drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 12/18/2008 | CA2690959A1 17.beta.-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/18/2008 | CA2689563A1 17.beta.-cyano-18a-homo-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/17/2008 | EP2003119A1 Substituted acetamides as modulators of EP2 receptors |
| 12/17/2008 | EP2002839A1 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/17/2008 | EP2002827A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 12/17/2008 | EP2001832A1 Methods and compositions for making and using polymorphs of cinacalcet |
| 12/17/2008 | EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/17/2008 | CN101326184A Bis-heterocyclic imidazolyl compounds |
| 12/17/2008 | CN101323604A Novel PPAR alpha/beta dual agonist, preparation and use thereof |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443104C A Chinese traditional medicinal embolus for treatment of hyperthyroidism and its preparation method |
| 12/17/2008 | CN100443077C Composition comprising cysteamine for improving lactation in dairy animals |
| 12/16/2008 | US7465722 Biphenyl vasopressin agonists |
| 12/11/2008 | WO2008148839A2 Long-acting polymeric prodrugs of exendin |
| 12/11/2008 | WO2008129303A3 Sustained release |
| 12/11/2008 | WO2008128791A3 Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen |
| 12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | DE102005015128B4 Wafer enthaltend Steroidhormone Wafer containing steroid hormones |
| 12/11/2008 | CA2689909A1 Long-acting polymeric prodrugs of exendin |
| 12/10/2008 | EP2000143A2 Transdermal gel compositions containing testosterone and their use for the treatment of fibromyalgia, chronic fatigue syndrome, muscle pain or decreased libido |
| 12/10/2008 | EP1999253A2 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| 12/10/2008 | EP1492501B1 Methods of using lamellar bodies for therapeutic purposes |
| 12/10/2008 | EP1379222B1 Orodispersible effervescent tablets |
| 12/10/2008 | CN101321524A Novel uses for estrogen beta agonists |
| 12/10/2008 | CN100441556C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 12/09/2008 | US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 12/09/2008 | CA2462998C Novel estrogenic compounds |
| 12/09/2008 | CA2321728C Epiallopregnanolone in the treatment of cns disorders |
| 12/04/2008 | WO2008147640A2 Hormone replacement therapy |
| 12/04/2008 | WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 12/04/2008 | WO2008080042A3 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles |
| 12/04/2008 | US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| 12/04/2008 | US20080300230 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones |
| 12/04/2008 | US20080300224 Treatment of conditions relating to hormone deficiencies by administration of progestins |
| 12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
| 12/04/2008 | CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity |
| 12/03/2008 | EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/03/2008 | EP1996212A2 Compounds from an extract of artemisia and methods for treating disorders |
| 12/03/2008 | EP1560573B1 Use of n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicyclo[2.2.1]hept-1-ylmethanesulfonamide family members in therapy |
| 12/03/2008 | EP1458700B1 Substituted 2-phenyl benzofurans as estrogenic agents |
| 12/03/2008 | EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 12/03/2008 | CN101316858A Sulfamoyl sulfonate prodrugs |
| 12/03/2008 | CN101316857A Prodrug ER-beta-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds |
| 12/03/2008 | CN101316856A Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 12/03/2008 | CN101316851A Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 12/03/2008 | CN101316603A Processes for obtaining lignan extracts and compositions containing the lignan extracts |
| 12/03/2008 | CN101316599A Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of NKT cell as active ingredient |
| 12/03/2008 | CN101316589A 糖尿病的治疗 Treatment of diabetes |
| 12/03/2008 | CN101314021A Chinese medicinal composition for dispelling wind and relieving paralysis |
| 12/03/2008 | CN101313926A Transcription regulating and controlling article composition |
| 12/03/2008 | CN101313920A Application of truffle extract in preparing foods, medicine for treating endocrine dyscrasia diseases |
| 12/03/2008 | CN100439920C Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100438875C Methods for increasing the therapeutic response to electroconvulsive therapy |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism |
| 12/02/2008 | CA2361841C Mevinolin derivatives |
| 12/02/2008 | CA2341624C Stable spray-dried protein formulations |
| 12/02/2008 | CA2303395C Treatment of obesity |
| 11/27/2008 | WO2008143262A1 Heterocyclic compound and use thereof |
| 11/27/2008 | WO2008109731A3 Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators |
| 11/27/2008 | US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof |
| 11/27/2008 | US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents |
| 11/27/2008 | US20080293693 Treatment or Prevention of Ovarian Hyperstimulation Syndrome (Ohss) Using a Dopamine Agonist |
| 11/27/2008 | US20080293683 Hormone Replacement Therapy |
| 11/27/2008 | US20080293116 Ovary-specific genes and proteins |
| 11/27/2008 | US20080292690 Multi-membrane immunoisolation system for cellular transplant |
| 11/27/2008 | US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/27/2008 | DE102004019743B4 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens Multiphase product for contraception based on a natural estrogen |
| 11/27/2008 | CA2685942A1 Spiroindalones |
| 11/26/2008 | EP1234574B1 Hair growth stimulant |
| 11/26/2008 | CN101312722A Modulators of atp-binding cassette transporters |
| 11/26/2008 | CN101310759A Biogenic source sex hormone starting replenisher |
| 11/26/2008 | CN100436452C Pyrazole compounds useful as protein kinase inhibitors |
| 11/26/2008 | CN100436439C Dimeric isoflavones |
| 11/26/2008 | CN100435848C Gene treatment to raise feed efficiency and promote growth of farm animal |
| 11/25/2008 | US7456201 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility |
| 11/25/2008 | US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract |
| 11/25/2008 | US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids |
| 11/25/2008 | US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody |
| 11/25/2008 | CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 11/20/2008 | WO2008139987A1 G-protein-conjugated receptor agonist |
| 11/20/2008 | WO2008138095A1 Composition for maintaining androgen and androgen-like uptake potential by cells |
| 11/20/2008 | WO2008113851A3 Novel c11 modified retrosteroids as progesterone receptor modulator compounds |
| 11/20/2008 | WO2008103707A8 Mono-and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile |
| 11/20/2008 | US20080287539 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 11/20/2008 | US20080287528 Therapeutic methods and compositions involving isoflavones |
| 11/20/2008 | US20080287501 Therapeutic uses of an insulin secretion enhancer |
| 11/20/2008 | US20080287444 Pyrazole compounds useful as protein kinase inhibitors |
| 11/20/2008 | US20080287423 Antidiabetic agents; neurodegenerative disorders; mixture with immunosuppresants |
| 11/20/2008 | US20080287390 Pyrazolidinol compounds |